Skip to main content
. 2020 Apr;8(8):544. doi: 10.21037/atm-20-2808

Table 1. Demographics and baseline characteristics of patients with four subtypes of breast cancer.

Characteristics All patients (n=227,989) Training cohort (n=113,996) Testing cohort (113,999)
Number of patients % Number of patients % Number of patients %
Age
   18–29 1,312 0.58 675 0.59 637 0.56
   30–39 10,532 4.62 5,198 4.56 5,334 4.68
   40–49 39,364 17.27 19,706 17.29 19,658 17.24
   50–59 58,777 25.78 29,349 25.75 29,428 25.82
   60–69 64,635 28.35 32,351 28.38 32,284 28.32
   70–79 39,275 17.23 19,683 17.27 19,592 17.19
   ≥80 14,094 6.18 7,034 6.17 7,060 6.19
Race
   White 181,350 79.54 90,727 79.59 90,623 79.50
   Black 24,372 10.69 12,116 10.63 12,256 10.75
   American Indian/Alaska Native 1,349 0.59 658 0.58 691 0.61
   Asian or Pacific Islander 20,918 9.18 10,495 9.21 10,423 9.14
Marital status
   Married 137,213 60.18 68,725 60.29 68,488 60.08
   Unmarried 90,776 39.82 45,271 39.71 45,505 39.92
Subtypes
   HR+/HER2− 170,135 74.62 85,005 74.57 85,130 74.68
   HR+/HER2+ 23,377 10.25 11,684 10.25 11,693 10.26
   HR−/HER2+ 9,083 3.98 4,545 3.99 4,538 3.98
   Triple negative 25,394 11.14 12,762 11.20 12,632 11.08
Histology
   Infiltrating duct carcinoma 174,174 76.40 87,054 76.37 87,120 76.43
   Lobular carcinoma 20,107 8.82 9,995 8.77 10,112 8.87
   Other 33,708 14.78 16,947 14.87 16,761 14.70
Location
   Nipple 752 0.33 364 0.32 388 0.34
   Central portion of breast 11,433 5.01 5,682 4.98 5,751 5.05
   Upper-inner quadrant of breast 32,717 14.35 16,389 14.38 16,328 14.32
   Lower-inner quadrant of breast 14,266 6.26 7,082 6.21 7,184 6.30
   Upper-outer quadrant of breast 89,370 39.20 44,831 39.33 44,539 39.07
   Lower-outer quadrant of breast 19,702 8.64 9,862 8.65 9,840 8.63
   Axillary tail of breast 1,131 0.50 566 0.50 565 0.50
   Overlapping lesion of breast 58,618 25.71 29,220 25.63 29,398 25.79
Laterality
   Right: origin of primary 112,772 49.46 56,601 49.65 56,171 49.28
   Left: origin of primary 115,217 50.54 57,395 50.35 57,822 50.72
Grade
   Well differentiated; Grade I 54,613 23.95 27,335 23.98 27,278 23.93
   Moderately differentiated; Grade II 100,854 44.24 50,321 44.14 50,533 44.33
   Poorly differentiated; Grade III 72,025 31.59 36,097 31.67 35,928 31.52
   Undifferentiated; anaplastic; Grade IV 497 0.22 243 0.21 254 0.22
Tumor size, cm
   ≤1 58,349 25.59 29,078 25.51 29,271 25.68
   ≤2 83,314 36.54 41,809 36.68 41,505 36.41
   ≤3 45,279 19.86 22,700 19.91 22,579 19.81
   ≤4 18,282 8.02 9,111 7.99 9,171 8.05
   ≤5 8,750 3.84 4,359 3.82 4,391 3.85
   >5 14,015 6.15 6,939 6.09 7,076 6.21
Positive regional nodes number
   0 162,133 71.11 81,105 71.15 81,028 71.08
   1–3 48,687 21.35 24,354 21.36 24,333 21.35
   4–9 11,831 5.19 5,831 5.12 6,000 5.26
   ≥10 5,338 2.34 2,706 2.37 2,632 2.31
Bone metastasis
   No 226,355 99.28 113,193 99.30 113,162 99.27
   Yes 1,634 0.72 803 0.70 831 0.73
Brain metastasis
   No 227,892 99.96 113,946 99.96 113,946 99.96
   Yes 97 0.04 50 0.04 47 0.04
Liver metastasis
   No 227,393 99.74 113,689 99.73 11,3704 99.75
   Yes 596 0.26 307 0.27 289 0.25
Lung metastasis
   No 227,342 99.72 113,662 99.71 113,680 99.73
   Yes 647 0.28 334 0.29 313 0.27